{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:41:28Z","timestamp":1778895688546,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vph.2008.06.002","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T09:18:54Z","timestamp":1213435134000},"page":"84-90","source":"Crossref","is-referenced-by-count":11,"title":["ACE-inhibition ameliorates vascular reactivity and delays diabetes outcome in NOD mice"],"prefix":"10.1016","volume":"49","author":[{"given":"Mariarosaria","family":"Bucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorentina","family":"Roviezzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Brancaleone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarita","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2008.06.002_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00005344-200109011-00002","article-title":"Anti-ischemic effect of angiotensin-converting enzyme inhibitors: a future therapeutic perspective","volume":"37","author":"Ambrosioni","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2008.06.002_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The survival of myocardial infarction long-term evaluation (SMILE) study investigators","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.vph.2008.06.002_bib3","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1056\/NEJM199411243312107","article-title":"The pathogenesis of insulin dependent diabetes","volume":"331","author":"Atkinson","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2008.06.002_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1067\/mhj.2003.24","article-title":"Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the survival of myocardial infarction long-term evaluation 2 (SMILE-2) study","volume":"145","author":"Borghi","year":"2003","journal-title":"Am. Heart. J."},{"issue":"4","key":"10.1016\/j.vph.2008.06.002_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/vhrm.2006.2.4.341","article-title":"Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data","volume":"2","author":"Borghi","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"issue":"3","key":"10.1016\/j.vph.2008.06.002_bib6","doi-asserted-by":"crossref","first-page":"445.e7","DOI":"10.1016\/j.ahj.2006.12.005","article-title":"Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study","volume":"153","author":"Borghi","year":"2007","journal-title":"Am. Heart. J."},{"key":"10.1016\/j.vph.2008.06.002_bib7","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.26.6.1862","article-title":"Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction","volume":"26","author":"Borghi","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2008.06.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.0000122362.44628.09","article-title":"Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression","volume":"24","author":"Bucci","year":"2004","journal-title":"Art. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2008.06.002_bib9","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/sj.bjp.0703498","article-title":"Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure","volume":"130","author":"Buikema","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2008.06.002_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/01.HYP.15.3.327","article-title":"Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit","volume":"15","author":"Chobanian","year":"1990","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.vph.2008.06.002_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/dmrr.780","article-title":"Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice","volume":"24","author":"Choi","year":"2008","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.vph.2008.06.002_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0895-7061(02)02995-3","article-title":"Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species","volume":"15","author":"Cominacini","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2008.06.002_bib13","doi-asserted-by":"crossref","first-page":"115S","DOI":"10.1111\/j.1365-2125.1989.tb03587.x","article-title":"Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE)","volume":"2","author":"Cushman","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.vph.2008.06.002_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/ajh\/2.4.294","article-title":"Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs","volume":"2","author":"Cushman","year":"1989","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2008.06.002_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/01.RES.68.2.450","article-title":"Angiotensin II induces smooth muscle cell proliferation in the normal injured rat arterial wall","volume":"68","author":"Daemen","year":"1991","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2008.06.002_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-5273(01)00542-3","article-title":"Chronic treatment with sulphydryl angiotensin-converting enzyme inhibitors reduce susceptibility of LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice","volume":"81","author":"de Nigris","year":"2001","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2008.06.002_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/147323000503300103","article-title":"Antioxudant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril","volume":"33","author":"Evangelista","year":"2005","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.vph.2008.06.002_bib18","article-title":"Tissue distribution of 14C a new angiotensin converting enzyme inhibitor with high affinity for the tissues in rats","volume":"1","author":"Evangelista","year":"2002"},{"key":"10.1016\/j.vph.2008.06.002_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"20","author":"Expert Committee on the diagnosis and classification of diabetes mellitus","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2008.06.002_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00005344-200402000-00020","article-title":"Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion","volume":"43","author":"Frascarelli","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2008.06.002_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/01.HYP.36.1.103","article-title":"Molecular plasticity of vascular wall during N(G)-nitro-l-arginine methyl ester-induced hypertension modulation of proinflammatory signals","volume":"36","author":"Gonzales","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2008.06.002_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autneu.2007.11.006","article-title":"Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice","volume":"138","author":"Gross","year":"2008","journal-title":"Auton. Neurosci.: Bas. Clin."},{"issue":"2","key":"10.1016\/j.vph.2008.06.002_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.imlet.2007.10.004","article-title":"Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles","volume":"115","author":"Han","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.vph.2008.06.002_bib24","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00005344-199804000-00011","article-title":"Antiatherosclerotic and antioxidative effect of captopril in apolipoprotein E deficient mice","volume":"31","author":"Hayek","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2008.06.002_bib25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0008-6363(99)00239-4","article-title":"The angiotensin-converting enzyme inhibitor, fosinopril and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice","volume":"44","author":"Hayek","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2008.06.002_bib26","doi-asserted-by":"crossref","first-page":"H91","DOI":"10.1152\/ajpheart.00472.2003","article-title":"Caveolin-1 regulates contractility in differentiated vascular smooth muscle","volume":"286","author":"Je","year":"2004","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"10.1016\/j.vph.2008.06.002_bib27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diabetes.45.9.1253","article-title":"Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM","volume":"45","author":"Jensen-Urstad","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2008.06.002_bib28","first-page":"153","article-title":"Reducing the burden of diabetes: managing cardiovascular disease","volume":"45","author":"Keen","year":"1999","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.vph.2008.06.002_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00005344-200001000-00008","article-title":"Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin","volume":"35","author":"Keidar","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2008.06.002_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1464-5491.1999.00071.x","article-title":"Angiotensin-converting enzyme gene and diabetes mellitus","volume":"16","author":"Kennon","year":"1999","journal-title":"Diabetic Med."},{"key":"10.1016\/j.vph.2008.06.002_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0065-2776(08)60490-3","article-title":"The murine autoimmune diabetes model: NOD and related strains","volume":"51","author":"Kikutani","year":"1992","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.vph.2008.06.002_bib32","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1152\/ajpendo.2001.280.1.E171","article-title":"Impairment of endothelial nitric oxide production by acute glucose overload","volume":"280","author":"Kimura","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2008.06.002_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0021-9150(94)90037-X","article-title":"Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids","volume":"108","author":"Kowala","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2008.06.002_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/qjmed\/94.2.89","article-title":"Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus","volume":"94","author":"Kventy","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.vph.2008.06.002_bib35","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy: the collaborative study group","volume":"329","author":"Lewis","year":"1993","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.vph.2008.06.002_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9150(98)00309-8","article-title":"Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits","volume":"143","author":"Li","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2008.06.002_bib37","first-page":"1","article-title":"Breeding of a non-obese diabetic strain of mice","volume":"29","author":"Makino","year":"1980","journal-title":"Jikken Dobutsu"},{"key":"10.1016\/j.vph.2008.06.002_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/abio.1993.1449","article-title":"A fluorimetric assay for the measurement of nitrite in biological samples","volume":"214","author":"Misko","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.vph.2008.06.002_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0306-3623(99)00043-9","article-title":"Beneficial effect of ACE-inhibition with zofenopril on plaque formation and low density lipoprotein oxidation in Watanabe heritable hyperlipidemic rabbits","volume":"33","author":"Napoli","year":"1999","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.vph.2008.06.002_bib40","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2337\/diacare.24.12.2091","article-title":"Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic\/beta-blocker-based treatment regimen: a subanalysis of the captopril prevention project","volume":"24","author":"Niskanen","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2008.06.002_bib41","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1365-2362.1999.00568.x","article-title":"Capillary permeability is increased in normo- and microalbuminuric type I diabetic patients: amelioration by ACE-inhibition","volume":"29","author":"Oomen","year":"1999","journal-title":"Eur. J. Clin. Inv."},{"issue":"4","key":"10.1016\/j.vph.2008.06.002_bib42","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjhyper.2006.09.020","article-title":"Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients","volume":"20","author":"Pasini","year":"2007","journal-title":"Am. Hypertens."},{"key":"10.1016\/j.vph.2008.06.002_bib43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00004","article-title":"Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial","volume":"128","author":"Ravid","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.vph.2008.06.002_bib44","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1097\/00004872-199112000-00073","article-title":"Aorta viscoelasticity and arterial histopathology of atherosclerotic pigs treated by angiotensin converting enzyme inhibition","volume":"9","author":"Rolland","year":"1991","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2008.06.002_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1590\/S0074-02762005000900004","article-title":"Regulation of endothelial nitric oxide in health and disease","volume":"100","author":"Sessa","year":"2005","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.vph.2008.06.002_bib46","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/diabetes.48.5.989","article-title":"Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse","volume":"48","author":"Sreenan","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2008.06.002_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1527-3466.1999.tb00008.x","article-title":"Preclinical profile of zofenopril: an angiotensin-converting enzyme inhibitor with peculiar cardioprotective properties","volume":"17","author":"Subissi","year":"1999","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.vph.2008.06.002_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00005344-199110000-00002","article-title":"Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril","volume":"18","author":"Sun","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2008.06.002_bib49","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.vph.2008.06.002_bib50","first-page":"6966","article-title":"Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agent flavone-8-acetic and xanthenone-4-acetic acid","volume":"50","author":"Thomsen","year":"1990","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.vph.2008.06.002_bib51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jcp.22.2.158","article-title":"Determination of blood glucose using an oxidase\u2013peroxidase system with a non-carcinogenic chromogen","volume":"22","author":"Trinder","year":"1969","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.vph.2008.06.002_bib52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effect of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. The heart outcomes prevention evaluation study investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189108000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189108000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T03:44:52Z","timestamp":1557632692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189108000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":52,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S1537189108000633"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2008.06.002","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}